VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

COSTEM 2019 | Aplastic anemia: treatment options in 2019

Antonio Risitano • 26 Oct 2019
COSTEM 2019
Anemia Aplastic Anemia Cyclosporine Eltrombopag

Antonio Risitano, MD, PhD, University of Naples Federico II, Naples, Italy, evaluates both immunosuppressive and transplant-based treatments for aplastic anemia. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Antonio Risitano

2:29
Unrelated transplantation vs. immunosuppression for SAA
Antonio Risitano • 25 Oct 2019

Related Videos

4:05
The 2021 MDS armamentarium
Felicitas Thol • 22 Jan 2021
5:58
CLIMB THAL-111 and CLIMB SCD-121: CTX001 in β-thalassemia and SCD
Haydar Frangoul • 10 Dec 2020
5:37
Allogeneic cord blood Treg infusion for BMF syndromes
Tapan Kadia • 3 Dec 2020
3:25
Multidisciplinary home approach for sickle cell disease
Wally Smith • 30 Nov 2020
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals